Galmed Pharmaceuticals Ltd. buy Piper Sandler
Start price
06.11.24
/
50%
€6.40
Target price
06.11.25
€93.31
Performance (%)
-
End price
07.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | -1.111% | 0.196% | 1.211% |
| iShares Nasdaq 100 | -4.346% | -3.249% | 25.873% |
| iShares Nikkei 225® | -6.785% | -7.717% | 50.968% |
| iShares S&P 500 | -1.788% | 0.993% | 21.073% |
Comments by Piper_Sandler for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Piper Sandler from $80.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd.
Stopped prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
15.06.26
15.06.26
€86.10
15.06.27
15.06.27
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
09.05.25
09.05.25
€71.34
09.05.26
09.05.26
-
10.05.26
10.05.26
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.37
20.05.24
20.05.24
€73.65
20.05.25
20.05.25
1648.63%
21.05.25
21.05.25